Infanrix Hexa
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for Infanrix Hexa, covering 2009-09-23 to 2026-07-10. Get the full timeline:
Most recent: EMA Authorised: Infanrix Hexa (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);hepatitis B surface antigen;poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain));Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.